BioSpace News Archive

This month, the National Association of Specialty Pharmacy awarded Adam Winstead, vice president of information technology at Amber Specialty Pharmacy, with its prestigious Specialty Pharmacy Service Excellence Award.

ALSA Ventures today announced first closing of its European biotechnology investment fund with commitments of US$59M.

With more than 40 states reporting increases in fatal opioid overdoses, the National Safety Council is urging both the Biden and Trump campaigns to include opioid overdose prevention as part of their COVID-19 recovery plans.

Annual program recognizes rising leaders who are making strides in the field of managed care research

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced that the European Commission (EC) has granted marketing authorization for Jyseleca® (filgotinib 200 mg and 100 mg tablets), a once-daily, oral,

AMDT Holdings, Inc. develops disruptive products to address existing and emerging needs in the extremity market. The flagship products for AMDT Holdings are the patented SixFix® Circular Fixation System, the patented SixFix Deformity Analysis and Correction Software, and the patented AMDT Mini-Rail.

RemeGen Co., Ltd. (“RemeGen”) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for disitamab vedotin (RC48), a novel h

U.S. Patent and Trademark Office Rejects IPR Challenge to Medtronic Patent Company Says No Final Determinations Have Been Made on Other Patents [25-September-2020] DUBLIN , Sept. 25, 2020 /PRNewswire/ -- Medtronic (NYSE:MDT) has won an important victory in a patent dispute over intellectual property for its sacral neuromodulation device family, the InterStim

- Fetal Hemoglobin expression in human cellular models increased up to ~30% by FTX-6058 for the potential treatment of sickle-cell disease - Company p lans to initiate Phase 1 trial in healthy volunteers by year-end - N on-provisional composition of matter patent application covering FTX-6058 published CAMBRIDGE, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving t

The American Pharmacists Association issued the following statement after the Food and Drug Administration finalized the rule for the legal importation of drugs from Canada: